Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study (Q27313709)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study |
scientific article |
Statements
1 reference
Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study (English)
1 reference
Massimo Loda
1 reference
Mary-Ellen Taplin
1 reference
Jerome P Richie
1 reference
Bruce Montgomery
1 reference
Christopher J Logothetis
1 reference
Glenn J Bubley
1 reference
Bruce L Dalkin
1 reference
Martin G Sanda
1 reference
John W Davis
1 reference
Lawrence D True
1 reference
Patricia Troncoso
1 reference
Huihui Ye
1 reference
Rosina T Lis
1 reference
Brett T Marck
1 reference
Alvin M Matsumoto
1 reference
Steven P Balk
1 reference
Elahe A Mostaghel
1 reference
Peter S Nelson
1 reference
Wanling Xie
1 reference
Zhenyang Jiang
1 reference
Christopher M Haqq
1 reference
Daniel Tamae
1 reference
NamPhuong Tran
1 reference
Weimin Peng
1 reference
Thian Kheoh
1 reference
Arturo Molina
1 reference
13 October 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference